Synopsis The global Gamma Knife market was valued at US$ 198.2 million in 2023 and is anticipated to reach US$ 247.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030. North American market for Gamma Knife is estim.....
SynopsisThe global Gastroesophageal Reflux Disease (GERD) Therapeutics market was valued at US$ 4801.8 million in 2023 and is anticipated to reach US$ 4286.6 million by 2030, witnessing a CAGR of -1.6% during the forecast period 2024-2030. North American market .....
Synopsis The global Gastrointestinal (GI) Stents market was valued at US$ 433 million in 2023 and is anticipated to reach US$ 590.9 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030. North American market for Gastr.....
SynopsisThe global Genetic Analysis Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Genetic Analysis Services is estimated t.....
Synopsis The global Genomics In Cancer Care market was valued at US$ 27620 million in 2023 and is anticipated to reach US$ 70990 million by 2030, witnessing a CAGR of 14.2% during the forecast period 2024-2030. North American market for Genomic.....
SynopsisThe global Geriatric Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Geriatric Medicine is estimated to increase fro.....
SynopsisThe global Glioblastoma Multiforme Treatment (GBM) market was valued at US$ 548.3 million in 2023 and is anticipated to reach US$ 996.4 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030. North American market for Glioblastom.....
SynopsisThe global Gonorrhea Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Gonorrhea Diagnostic is estimated to increase.....
SynopsisThe global Group 2 Powered Mobility Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Group 2 Powered Mobility Devices .....
SynopsisThe global Head and Neck Cancer Drugs & Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Head and Neck Cancer Dru.....
